Nanomaterials for the local and targeted delivery of osteoarthritis drugs

Journal of Nanomaterials

Volumn 2012, Issue , 2012, Pages

  Chinnagounder Periyasamy, Parthiban ^a   Leijten, Jeroen C H ^a   Dijkstra, Pieter J ^a   Karperien, Marcel ^a   Post, Janine N ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUILDING BLOCKES; CARTILAGE REPAIR; CLINICAL APPLICATION; CURRENT TREATMENTS; DELIVERY SYSTEMS; DESIGN TOOL; DRUG DELIVERY SYSTEM; MACROSYSTEMS; NANO SCALE; NANO-METER SCALE; NATURALLY OCCURRING; SCIENCE AND ENGINEERING; SIDE EFFECT; SYNTHETIC POLYMERS; TARGETED DELIVERY;

CARTILAGE; DISEASE CONTROL; DRUG DELIVERY; DRUG INTERACTIONS; NANOPARTICLES; NANOTECHNOLOGY; PROTEINS;

NANOSTRUCTURED MATERIALS;

EID: 84862290921     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2012/673968     Document Type: Review

References (110)

1. Gerwin N., Hops C., Lucke A., Intraarticular drug delivery in osteoarthritis Advanced Drug Delivery Reviews 2006 58 2 226 242
2. Attur M., Samuels J., Krasnokutsky S., Abramson S. B., Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence? Best Practice and Research 2010 24 1 71 79
3. Lories R. J., Luyten F. P., The bone-cartilage unit in osteoarthritis Nature Reviews Rheumatology 2011 7 1 43 49
4. Suri S., Walsh D. A., Osteochondral alterations in osteoarthritis. Bone. In press
5. Goldring M. B., Goldring S. R., Osteoarthritis Journal of Cellular Physiology 2007 213 3 626 634 (Pubitemid 350058254)
6. Bijlsma J. W. J., Berenbaum F., Lafeber F. P. J. G., Osteoarthritis: an update with relevance for clinical practice The Lancet 2011 377 9783 2115 2126
7. Kock L., van Donkelaar C. C., Ito K., Tissue engineering of functional articular cartilage: the current status Cell and Tissue Research 2012 347 3 613 627
8. Reddi A. H., Becerra J., Andrades J. A., Nanomaterials and hydrogel scaffolds for articular cartilage regeneration Tissue EngineeringPart B 2011 17 5 301 305
9. Bertrand J., Cromme C., Umlauf D., Frank S., Pap T., Molecular mechanisms of cartilage remodelling in osteoarthritis International Journal of Biochemistry and Cell Biology 2010 42 10 1594 1601
10. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J. P., Fahmi H., Role of proinflammatory cytokines in the pathophysiology of osteoarthritis Nature Reviews Rheumatology 2011 7 1 33 42
11. Mueller M. B., Tuan R. S., Anabolic/Catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets PM R 2011 3 6, supplement 1 S3 S11
12. Andriacchi T. P., Mndermann A., The role of ambulatory mechanics in the initiation and progression of knee osteoarthritis Current Opinion in Rheumatology 2006 18 5 514 518 (Pubitemid 44200338)
13. Alcaraz M. J., Megas J., Garca-Arnandis I., Clérigues V., Guillén M. I., New molecular targets for the treatment of osteoarthritis Biochemical Pharmacology 2010 80 1 13 21
14. Beyer C., Schett G., Novel targets in bone and cartilage Best Practice and Research 2010 24 4 489 496
15. Marcu K. B., Otero M., Olivotto E., Borzi R. M., Goldring M. B., NF- B signaling: multiple angles to target OA Current Drug Targets 2010 11 5 599 613
16. O'Neill L. A. J., Targeting signal transduction as a strategy to treat inflammatory diseases Nature Reviews Drug Discovery 2006 5 7 549 563 (Pubitemid 43971190)
17. Talekar M., Kendall J., Denny W., Garg S., Targeting of nanoparticles in cancer: drug delivery and diagnostics Anti-Cancer Drugs 2011 22 10 949 962
18. Chi X., Huang D., Zhao Z., Zhou Z., Yin Z., Gao J., Nanoprobes for in vitro diagnostics of cancer and infectious diseases Biomaterials 2012 33 1 189 206
19. Shanholtz C., Acute life-threatening toxicity of cancer treatment Critical Care Clinics 2001 17 3 483 502 (Pubitemid 32777560)
20. Lammers T., Kiessling F., Hennink W. E., Storm G., Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. Journal of Controlled Release. In press
21. Kataoka K., Harada A., Nagasaki Y., Block copolymer micelles for drug delivery: design, characterization and biological significance Advanced Drug Delivery Reviews 2001 47 1 113 131 (Pubitemid 32209236)
22. Francis M. F., Cristea M., Winnik F. M., Polymeric micelles for oral drug delivery: why and how Pure and Applied Chemistry 2004 76 7-8 1321 1335
23. Yokoyama M., Kwon G. S., Okano T., Sakurai Y., Seto T., Kataoka K., Preparation of micelle-forming polymer-drug conjugates Bioconjugate Chemistry 1992 3 4 295 301
24. Kedar U., Phutane P., Shidhaye S., Kadam V., Advances in polymeric micelles for drug delivery and tumor targeting Nanomedicine 2010 6 6 714 729
25. Mahmud A., Xiong X. B., Aliabadi H. M., Lavasanifar A., Polymeric micelles for drug targeting Journal of Drug Targeting 2007 15 9 553 584 (Pubitemid 350031081)
26. Oerlemans C., Bult W., Bos M., Storm G., Nijsen J. F. W., Hennink W. E., Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharmaceutical Research 2010 1 21
27. Osada K., Christie R. J., Kataoka K., Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery Journal of the Royal Society Interface 2009 6 3 S325 S339
28. Kataoka K., Kwon G. S., Yokoyama M., Okano T., Sakurai Y., Block copolymer micelles as vehicles for drug delivery Journal of Controlled Release 1993 24 13 119 132 (Pubitemid 23161325)
29. Miyata K., Christie R. J., Kataoka K., Polymeric micelles for nano-scale drug delivery Reactive and Functional Polymers 2011 71 3 227 234
30. Chen H., Khemtong C., Yang X., Chang X., Gao J., Nanonization strategies for poorly water-soluble drugs Drug Discovery Today 2011 16 7-8 354 360
31. Rothenfluh D. A., Bermudez H., O'Neil C. P., Hubbell J. A., Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage Nature Materials 2008 7 3 248 254 (Pubitemid 351311300)
32. Singer I. I., Kawka D. W., Bayne E. K., Donatelli S. A., Weidner J. R., Williams H. R., Ayala J. M., Mumford R. A., Lark M. W., Glant T. T., Nabozny G. H., David C. S., VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis The Journal of Clinical Investigation 1995 95 5 2178 2186
33. Schwendener R. A., Liposomes in biology and medicine Advances in Experimental Medicine and Biology 2007 620 117 128
34. Torchilin V. P., Recent advances with liposomes as pharmaceutical carriers Nature Reviews Drug Discovery 2005 4 2 145 160 (Pubitemid 40282557)
35. Yang F., Jin C., Jiang Y., Li J., Di Y., Ni Q., Fu D., Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside Cancer Treatment Reviews 2011 37 8 633 642
36. Slingerland M., Guchelaar H.-J., Gelderblom H., Liposomal drug formulations in cancer therapy: 15 years along the road Drug Discovery Today 2012 17 3-4 160 166
37. Czech M. P., Aouadi M., Tesz G. J., RNAi-based therapeutic strategies for metabolic disease Nature Reviews Endocrinology 2011 7 8 473 484
38. Campbell R. B., Ying B., Kuesters G. M., Hemphill R., Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics Journal of Pharmaceutical Sciences 2009 98 2 411 429
39. Gabizon A., Shmeeda H., Horowitz A. T., Zalipsky S., Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates Advanced Drug Delivery Reviews 2004 56 8 1177 1192 (Pubitemid 38496514)
40. Lu Y., Low P. S., Folate-mediated delivery of macromolecular anticancer therapeutic agents Advanced Drug Delivery Reviews 2002 54 5 675 693 (Pubitemid 35247522)
41. Li H., Qian Z. M., Transferrin/transferrin receptor-mediated drug delivery Medicinal Research Reviews 2002 22 3 225 250 (Pubitemid 34415465)
42. Zhai G., Wu J., Yu B., Guo C., Yang X., Lee R. J., A transferrin receptor-targeted liposomal formulation for docetaxel Journal of Nanoscience and Nanotechnology 2010 10 8 5129 5136
43. Srinivasan R., Marchant R. E., Gupta A. S., In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes Journal of Biomedical Materials ResearchPart A 2010 93 3 1004 1015
44. Fattahi H., Laurent S., Liu F., Arsalani N., Elst L. V., Muller R. N., Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics Nanomedicine 2011 6 3 529 544
45. Mulder W. J. M., Strijkers G. J., van Tilborg G. A. F., Griffioen A. W., Nicolay K., Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging NMR in Biomedicine 2006 19 1 142 164 (Pubitemid 43250800)
46. Torchilin V. P., Levchenko T. S., Whiteman K. R., Yaroslavov A. A., Tsatsakis A. M., Rizos A. K., Michailova E. V., Shtilman M. I., Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification Biomaterials 2001 22 22 3035 3044 (Pubitemid 32768711)
47. Yamskov I. A., Kuskov A. N., Babievsky K. K., Berezin B. B., Krayukhina M. A., Samoylova N. A., Tikhonov V. E., Shtilman M. I., Novel liposomal forms of antifungal antibiotics modified by amphiphilic polymers Applied Biochemistry and Microbiology 2008 44 6 624 628
48. Nakano K., Tozuka Y., Takeuchi H., Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells International Journal of Pharmaceutics 2008 354 1-2 174 179 (Pubitemid 351400326)
49. Ishihara A., Yamauchi M., Kusano H., Mimura Y., Nakakura M., Kamiya M., Katagiri A., Kawano M., Nemoto H., Suzawa T., Yamasaki M., Preparation and properties of branched oligoglycerol modifiers for stabilization of liposomes International Journal of Pharmaceutics 2010 391 1-2 237 243
50. Elron-Gross I., Glucksam Y., Margalit R., Liposomal dexamethasone- diclofenac combinations for local osteoarthritis treatment International Journal of Pharmaceutics 2009 376 1-2 84 91
51. Goldberg R., Schroeder A., Barenholz Y., Klein J., Interactions between adsorbed hydrogenated soy phosphatidylcholine (HSPC) vesicles at physiologically high pressures and salt concentrations Biophysical Journal 2011 100 10 2403 2411
52. Goldberg R., Schroeder A., Silbert G., Turjeman K., Barenholz Y., Klein J., Boundary lubricants with exceptionally low friction coefficients based on 2D close-packed phosphatidylcholine liposomes Advanced Materials 2011 23 31 3517 3521
53. Trie M., Guillen C., Vaughan D. M., Telfer J. M., Brewer J. M., Roseanu A., Brock J. H., Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases Experimental Biology and Medicine 2001 226 6 559 564 (Pubitemid 32524502)
54. Torchilin V. P., Lukyanov A. N., Gao Z., Papahadjopoulos-Sternberg B., Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 6039 6044 (Pubitemid 36576927)
55. Vega J., Ke S., Fan Z., Wallace S., Charsangavej C., Li C., Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer Pharmaceutical Research 2003 20 5 826 832 (Pubitemid 36515318)
56. Palanca-Wessels M. C., Convertine A. J., Cutler-Strom R., Booth G. C., Lee F., Berguig G. Y., Stayton P. S., Press O. W., Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells Molecular Therapy 2011 19 8 1529 1537
57. Nasongkla N., Shuai X., Ai H., Weinberg B. D., Pink J., Boothman D. A., Gao J., cRGD-functionalized polymer micelles for targeted doxorubicin delivery Angewandte ChemieInternational Edition 2004 43 46 6323 6327 (Pubitemid 40029462)
58. Koo O. M. Y., Rubinstein I., nyksel H., Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis Pharmaceutical Research 2011 28 4 776 787
59. Shao K., Huang R., Li J., Han L., Ye L., Lou J., Jiang C., Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain Journal of Controlled Release 2010 147 1 118 126
60. Yoo H. S., Park T. G., Folate receptor targeted biodegradable polymeric doxorubicin micelles Journal of Controlled Release 2004 96 2 273 283 (Pubitemid 38481509)
61. Park E. K., Lee S. B., Lee Y. M., Preparation and characterization of methoxy poly(ethylene glycol)/poly( -caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs Biomaterials 2005 26 9 1053 1061 (Pubitemid 39208991)
62. Han X., Liu J., Liu M., Xie C., Zhan C., Gu B., Liu Y., Feng L., Lu W., 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro International Journal of Pharmaceutics 2009 372 1-2 125 131
63. Wang Y. C., Liu X. Q., Sun T. M., Xiong M. H., Wang J., Functionalized micelles from block copolymer of polyphosphoester and poly(e{open}-caprolactone) for receptor-mediated drug delivery Journal of Controlled Release 2008 128 1 32 40
64. Newkome G. R., Shreiner C. D., Poly(amidoamine), polypropylenimine, and related dendrimers and dendrons possessing different 1 → 2 branching motifs: an overview of the divergent procedures Polymer 2008 49 1 1 173
65. Hawker C. J., Fréchet J. M. J., Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules Journal of the American Chemical Society 1990 112 21 7638 7647
66. Joralemon M. J., O'Reilly R. K., Matson J. B., Nugent A. K., Hawker C. J., Wooley K. L., Dendrimers clicked together divergently Macromolecules 2005 38 13 5436 5443 (Pubitemid 41028111)
67. Killops K. L., Campos L. M., Hawker C. J., Robust, efficient, and orthogonal synthesis of dendrimers via thiol-ene click chemistry Journal of the American Chemical Society 2008 130 15 5062 5064 (Pubitemid 351537066)
68. Brauge L., Magro G., Caminade A. M., Majoral J. P., First divergent strategy using two AB2 unprotected monomers for the rapid synthesis of dendrimers Journal of the American Chemical Society 2001 123 27 6698 6699 (Pubitemid 32916465)
69. Slany M., Caminade A. M., Majoral J. P., Specific functionalization on the surface of dendrimers Tetrahedron Letters 1996 37 50 9053 9056 (Pubitemid 26400462)
70. Wu P., Malkoch M., Hunt J. N., Vestberg R., Kaltgrad E., Finn M. G., Fokin V. V., Sharpless K. B., Hawker C. J., Multivalent, bifunctional dendrimers prepared by click chemistry Chemical Communications 2005 46 5775 5777 (Pubitemid 43028751)
71. Patri A. K., Kukowska-Latallo J. F., Baker J. R., Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex Advanced Drug Delivery Reviews 2005 57 15 2203 2214 (Pubitemid 41759393)
72. Liu M., Kono K., Fréchet J. M. J., Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents Journal of Controlled Release 2000 65 1-2 121 131 (Pubitemid 30122921)
73. Kojima C., Kono K., Maruyama K., Takagishi T., Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs Bioconjugate Chemistry 2000 11 6 910 917
74. Svenson S., Dendrimers as versatile platform in drug delivery applications European Journal of Pharmaceutics and Biopharmaceutics 2009 71 3 445 462
75. Lim J., Chouai A., Lo S. T., Liu W., Sun X., Simanek E. E., Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages Bioconjugate Chemistry 2009 20 11 2154 2161
76. Quintana A., Raczka E., Piehler L., Lee I., Myc A., Majoros I., Patri A. K., Thomas T., Mulé J., Baker J. R., Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor Pharmaceutical Research 2002 19 9 1310 1316
77. Dutta T., Agashe H. B., Garg M., Balasubramanium P., Kabra M., Jain N. K., Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro Journal of Drug Targeting 2007 15 1 89 98 (Pubitemid 47161336)
78. Yang W., Cheng Y., Xu T., Wang X., Wen L. P., Targeting cancer cells with biotin-dendrimer conjugates European Journal of Medicinal Chemistry 2009 44 2 862 868
79. Zinselmeyer B. H., Mackay S. P., Schatzlein A. G., Uchegbu I. F., The lower-generation polypropylenimine dendrimers are effective gene-transfer agents Pharmaceutical Research 2002 19 7 960 967 (Pubitemid 34808705)
80. Tack F., Bakker A., Maes S., Dekeyser N., Bruining M., Elissen-Roman C., Janicot M., Brewster M., Janssen H. M., De Waal B. F. M., Fransen P. M., Lou X., Meijer E. W., Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes) Journal of Drug Targeting 2006 14 2 69 86
81. Luo D., Haverstick K., Belcheva N., Han E., Saltzman W. M., Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery Macromolecules 2002 35 9 3456 3462 (Pubitemid 34590324)
82. Winalski C. S., Shortkroff S., Schneider E., Yoshioka H., Mulkern R. V., Rosen G. M., Targeted dendrimer-based contrast agents for articular cartilage assessment by MR imaging Osteoarthritis and Cartilage 2008 16 7 815 822
83. Hayder M., Poupot M., Baron M., Nigon D., Turrin C.-O., Caminade A.-M., Majoral J.-P., Eisenberg R. A., Fournié J.-J., Cantagrel A., Poupot R., Davignon J.-L., A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis Science Translational Medicine 2011 3 81
84. Svenson S., Tomalia D. A., Dendrimers in biomedical applicationsreflections on the field Advanced Drug Delivery Reviews 2005 57 15 2106 2129
85. Acharya S., Sahoo S. K., PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Advanced Drug Delivery Reviews 2011 63 3 170 183
86. Chan J. M., Zhang L., Tong R., Ghosh D., Gao W., Liao G., Yuet K. P., Gray D., Rhee J. W., Cheng J., Golomb G., Libby P., Langer R., Farokhzad O. C., Spatiotemporal controlled delivery of nanoparticles to injured vasculature Proceedings of the National Academy of Sciences of the United States of America 2010 107 5 2213 2218
87. Soppimath K. S., Aminabhavi T. M., Kulkarni A. R., Rudzinski W. E., Biodegradable polymeric nanoparticles as drug delivery devices Journal of Controlled Release 2001 70 1-2 1 20 (Pubitemid 32144788)
88. Zambaux M. F., Bonneaux F., Gref R., Dellacherie E., Vigneron C., Preparation and characterization of protein C-loaded PLA nanoparticles Journal of Controlled Release 1999 60 2-3 179 188 (Pubitemid 29335944)
89. Owens D. E., Peppas N. A., Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles International Journal of Pharmaceutics 2006 307 1 93 102 (Pubitemid 41773257)
90. Kim S. Y., Lee Y. M., Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly( -caprolactone) as novel anticancer drug carriers Biomaterials 2001 22 13 1697 1704 (Pubitemid 32564958)
91. Prabha S., Labhasetwar V., Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells Molecular Pharmaceutics 2004 1 3 211 219
92. Nune S. K., Gunda P., Thallapally P. K., Lin Y. Y., Forrest M. L., Berkland C. J., Nanoparticles for biomedical imaging Expert Opinion on Drug Delivery 2009 6 11 1175 1194
93. Mahapatro A., Singh D. K., Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines Journal of Nanobiotechnology 2011 9, article 55
94. Liu Y., Miyoshi H., Nakamura M., Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles International Journal of Cancer 2007 120 12 2527 2537 (Pubitemid 46651272)
95. Willoughby D. A., Moore A. R., Colville-Nash P. R., COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease The Lancet 2000 355 9204 646 648 (Pubitemid 30099478)
96. Antman E. M., Bennett J. S., Daugherty A., Furberg C., Roberts H., Taubert K. A., Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association Circulation 2007 115 12 1634 1642 (Pubitemid 46648649)
97. Dray A., Read S. J., Arthritis and pain. Future targets to control osteoarthritis pain Arthritis Research and Therapy 2007 9 3, article 212
98. Herrero-Beaumont G., Romn Ivorra J. A., Trabado M. D. C., Blanco F. J., Benito P., Martn-Mola E., Paulino J., Marenco J. L., Porto A., Laffon A., Arajo D., Figueroa M., Branco J., Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator Arthritis and Rheumatism 2007 56 2 555 567
99. Wildi L. M., Raynauld J.-P., Martel-Pelletier J., Beaulieu A., Bessette L., Morin F., Abram F., Dorais M., Pelletier J.-P., Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI Annals of the Rheumatic Diseases 2011 70 6 982 989
100. Pavelka K., Tr T., Karpa K., Vtek P., Sedlkov M., Vlaskov V., Bhmov J., Rovensk J., The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period Arthritis and Rheumatism 2007 56 12 4055 4064 (Pubitemid 350262333)
101. Bhm C., Hayer S., Kilian A., Zaiss M. M., Finger S., Hess A., Engelke K., Kollias G., Krnke G., Zwerina J., Schett G., David J. P., The -isoform of p38 MAPK specifically regulates arthritic bone loss Journal of Immunology 2009 183 9 5938 5947
102. Brown K. K., Heitmeyer S. A., Hookfin E. B., Hsieh L., Buchalova M., Taiwo Y. O., Janusz M. J., P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis Journal of Inflammation 2008 5, article 22
103. Lee M. R., Dominguez C., MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38 protein Current Medicinal Chemistry 2005 12 25 2979 2994 (Pubitemid 41672487)
104. Edwards S. H. R., Intra-articular drug delivery: the challenge to extend drug residence time within the joint Veterinary Journal 2011 190 1 15 21
105. Nakasa T., Nagata Y., Yamasaki K., Ochi M., A mini-review: microRNA in arthritis Physiological Genomics 2011 43 10 566 570
106. Clutterbuck A. L., Asplin K. E., Harris P., Allaway D., Mobasheri A., Targeting matrix metalloproteinases in inflammatory conditions Current Drug Targets 2009 10 12 1245 1254
107. Comper W. D., Cartilage: Molecular Aspects 1991 CRC Press
108. Torzilli P. A., Arduino J. M., Gregory J. D., Bansal M., Effect of proteoglycan removal on solute mobility in articular cartilage Journal of Biomechanics 1997 30 9 895 902 (Pubitemid 27409996)
109. Ushiyama T., Chano T., Inoue K., Matsusue Y., Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids Annals of the Rheumatic Diseases 2003 62 2 108 112 (Pubitemid 36135384)
110. Sellam J., Berenbaum F., The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis Nature Reviews Rheumatology 2010 6 11 625 635